Contents Imaging


Positron Emission Tomography–Computed Tomography Evaluation of Maxillary Rhabdomyosarcoma in an Adult


Regino Cube, MD,1 Yang-En Kao, MD2 and Stephen Yoest, MD3


1. Resident, Department of Radiology; 2. Chief, Department of Nuclear Medicine; 3. Attending Neuroradiologist, Department of Radiology, Madigan Army Medical Center


Positron-emission Tomography Imaging in Breast Cancer William B Eubank, MD,1


Jean H Lee, MD2 130 and David A Mankoff, MD, PhD3


1. Associate Professor of Radiology, Puget Sound VA Health Care System; 2. Assistant Professor of Radiology; 3. Professor of Radiology, University of Washington and Seattle Cancer Care Alliance


Hematological Malignancies


Molecular Monitoring of BCR-ABL Transcripts—Standardization Needed to Properly Use, and Further Investigate the Value of, a Critical Surrogate Marker for Success in Therapy of Chronic Myeloid Leukemia


Francis J Giles, MB, MD, FRCPI, FRCPath


Director, HRB Clinical Research Facility, National University of Ireland, Galway, and Professor of Cancer Therapeutics, National University of Ireland, Galway and Trinity College, Dublin


Treatment Options for Myelodysplastic Syndromes Hillary Prescott, PharmD, BCOP,1


Elias Jabbour, MD,2 and Hagop Kantarjian, MD3


1. Clinical Pharmacy Specialist; 2. Assistant Professor; 3. Chair, Department of Leukemia, The University of Texas MD Anderson Cancer Center


Von Willebrand Disease


Von Willebrand Disease Screening in Adolescents with Menorrhagia— A Decision Analysis and Review


Robert Francis Sidonio, Jr, MD1 and Margaret V Ragni, MD, MPH2


1. Assistant Professor of Medicine, Division of Pediatric Hematology/Oncology, Children’s Hospital at Vanderbildt; 2. Professor of Medicine, Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh, and Director, Hemophilia Center of Western Pennsylvania


Extracellular Hemoglobin Regulation of von Willebrand Factor Activity in Plasma of Patients with Sickle Cell Disease


Zhou Zhou, MD, PhD1 and Prasenjit Guchhait, PhD2


1. Post-doctoral Fellow; 2. Assistant Professor, Thrombosis Research Division, Cardiovascular Research Section, Department of Medicine, Baylor College of Medicine


Transplantation


Allogeneic Hematopoietic Stem Cell Donation—Current Status with Regard to Safety


Alberto Bosi, MD1 and Benedetta Bartolozzi, MD2


1. Full Professor of Hematology; 2. Fellow, Department of Hematology, Bone Marrow Transplantation Unit, University of Florence


Thalassemia


Thalassemia as a Hypercoagulable State Maria D Cappellini, MD,1


157 Khaled M Musallam, MD2 and Ali T Taher, MD3


1. Professor of Medicine, Department of Internal Medicine, Fondazione IRCCS “Ca’ Granda” Ospedale Policlinico, University of Milan; 2. Clinical Research Fellow; 3. Professor of Medicine, Department of Internal Medicine, Hematology–Oncology Division, American University of Beirut Medical Center


86 US ONCOLOGY & HEMATOLOGY 153 150 146 143 Jeffrey Bryan, PharmD1 138 126


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84